Huawei’s David Wang: Defining 5.5G for a Better, Intelligent World

SHANGHAI, Nov. 16, 2020 /PRNewswire/ — At the 2020 Global Mobile Broadband Forum (MBBF), David Wang,…

BlueSignal’s 3 solutions towards future traffic: Signal Optimizer, Safe Driving Advisor, and Congestion Prediction

SEOUL, South Korea, Nov. 16, 2020 /PRNewswire/ –– BlueSignal, a member company of the Born2Global Centre…

Hebron Announces Name Change to Nisun International Enterprise Development Group Co., Ltd

SHANGHAI and WENZHOU, China, Nov. 16, 2020 /PRNewswire/ — Hebron Technology Co., Ltd. ("Hebron" or the…

Guardforce AI Bolsters its Services with Cybersecurity Offering and Robot as a Service Solution

BANGKOK, Nov. 16, 2020 /PRNewswire/ — Guardforce AI Co., Ltd. (OTC Pink: GRDAF) ("Guardforce AI"), a trusted…

Tantech Subsidiary Launches Innovative Driverless and Autonomous Street Sweepers

LISHUI, China, Nov. 16, 2020 /PRNewswire/ — Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"),…

Global accessory wholesale platform, FUNNYZOOM, launched by Korea’s No.1 fashion accessory brand, N.CAT, is aiming for the global market

SEOUL, South Korea, Nov. 16, 2020 /PRNewswire/ — Global ‘K-Jewelry’ wholesale platform FUNNYZOOM (www.funnyzoom.com) was launched…

Schmidt Futures and Rhodes Trust Launch Global “Rise” Program to Find the Next Generation of Leaders and Support Them for Life

Youth Talent Program Supported by Eric and Wendy Schmidt Seeks Extraordinary 15-17-Year-Olds Committed to Tackling World’s…

IBM to Acquire SAP Consulting Partner TruQua

Acquisition will bolster IBM Services’ expertise in financial workflows with SAP and further strengthen the company’s…

Specialty Chemical Company China XD Plastics Announces Third Quarter 2020 Financial Results

– Revenue of $290.1 million – HARBIN, China, Nov. 16, 2020 /PRNewswire/ — China XD Plastics…

Harbour BioMed Will Present Results From Its Phase II Clinical Trial with Tanfanercept (HBM9036) in Patients with Moderate-to-Severe Dry Eye Disease in China at the 25th Congress of Chinese Ophthalmological Society

The proof-of-concept study demonstrated efficacy, safety, and tolerability of Tanfanercept for the treatment of moderate-to-severe dry…